Single-dose and steady-state pharmacokinetics of eslicarbazepine acetate (BIA 2-093) in healthy elderly and young subjects

被引：86

作者：

Almeida, L

Falcao, A

Maia, J

Mazur, D

Gellert, M

Soares-da-Silva, P ^{[1
]}

机构：

[1] BIAL Portela & C SA, Dept Res & Dev, P-4745457 S Mamede Do Coronado, Portugal

[2] Scope Int Life Sci AG, Hamburg, Germany

来源：

JOURNAL OF CLINICAL PHARMACOLOGY | 2005年 / 45卷 / 09期

关键词：

eslicarbazepine acetate; eslicarbazepine; BIA; 2-093; age effect; elderly; pharmocokinetics;

D O I：

10.1177/0091270005279364

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：1062 / 1066

页数：5

共 14 条

[1] Safety, tolerability, and pharmacokinetic profile of BIA 2-093, a novel putative antiepileptic, in a rising multiple-dose study in young healthy humans [J].

Almeida, L ;

Soares-da-Silva, P .

JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 44 (08) :906-918

[2] Safety, tolerability and pharmacokinetic profile of BIA 2-093, a novel putative antiepileptic agent, during first administration to humans [J].

Luis Almeida ;

Patrício Soares-da-Silva .

Drugs in R & D, 2003, 4 (5) :269-284

[3] Anticonvulsant and sodium channel-blocking properties of novel 10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide derivatives [J].

Benes, J ;

Parada, A ;

Figueiredo, AA ;

Alves, PC ;

Freitas, AP ;

Learmonth, DA ;

Cunha, RA ;

Garrett, J ;

Soares-da-Silva, P .

JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (14) :2582-2587

[4] Interaction of the novel anticonvulsant, BIA 2-093, with voltage-gated sodium channels:: Comparison with carbamazepine [J].

Bonifácio, MJ ;

Sheridan, RD ;

Parada, A ;

Cunha, RA ;

Patmore, L ;

Soares-da-Silva, P .

EPILEPSIA, 2001, 42 (05) :600-608

[5] EFFECTIVE HALF-LIFE IN CLINICAL-PHARMACOLOGY [J].

BOXENBAUM, H ;

BATTLE, M .

JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 35 (08) :763-766

[6]

Faigle J W, 1990, Behav Neurol, V3, P21, DOI 10.3233/BEN-1990-31S104

[7] DETERMINATION OF THE R-(-) AND S-(+) ENANTIOMERS OF THE MONOHYDROXYLATED METABOLITE OF OXCARBAZEPINE IN HUMAN PLASMA BY ENANTIOSELECTIVE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].

FLESCH, G ;

FRANCOTTE, E ;

HELL, F ;

DEGEN, PH .

JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1992, 581 (01) :147-151

[8] CLINICAL-PHARMACOLOGY AND PHARMACOKINETICS OF OXCARBAZEPINE [J].

LLOYD, P ;

FLESCH, G ;

DIETERLE, W .

EPILEPSIA, 1994, 35 :S10-S13

[9]

Maia J, 2004, EPILEPSIA, V45, P158

[10] THE METABOLISM OF OXCARBAZEPINE-C-14 IN MAN [J].

SCHUTZ, H ;

FELDMANN, KF ;

FAIGLE, JW ;

KRIEMLER, HP ;

WINKLER, T .

XENOBIOTICA, 1986, 16 (08) :769-778

← 1 2 →